(4aS,7aR)-tert-Butyl hexahydropyrrolo[3,4-b][1,4]oxazine-4(4aH)-carboxylate

Catalog No. :
ACDKJE961
CAS No. :
1932146-99-0
Molecular Formula :
C11H20N2O3
Molecular Weight :
228.29

IUPAC Name:tert-butyl (4aS,7aR)-hexahydropyrrolo[3,4-b][1,4]oxazine-4(4aH)-carboxylate

(4aS,7aR)-tert-Butyl hexahydropyrrolo[3,4-b][1,4]oxazine-4(4aH)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$926.00Login to see priceIn stockInquiry
250mg97%$1481.00Login to see priceIn stockInquiry
500mg97%$2466.00Login to see priceIn stockInquiry
1g97%$3699.00Login to see priceIn stockInquiry
5g97%$11095.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4aS,7aR)-tert-Butyl hexahydropyrrolo[3,4-b][1,4]oxazine-4(4aH)-carboxylate
IUPAC Nametert-butyl (4aS,7aR)-hexahydropyrrolo[3,4-b][1,4]oxazine-4(4aH)-carboxylate
Molecular FormulaC11H20N2O3
Molecular Weight228.29
SMILESO=C(N1[C@]2([H])[C@](CNC2)([H])OCC1)OC(C)(C)C
InChI KeyYLMNCYATSGIUDS-DTWKUNHWSA-N
Synonymtert-butyl (4aS,7aR)-hexahydropyrrolo[3,4-b][1,4]oxazine-4(4aH)-carboxylate;Pyrrolo[3,4-b]-1,4-oxazine-4(4aH)-carboxylic acid, hexahydro-, 1,1-dimethylethyl ester, (4aS,7aR)-;tert-butyl (4aS,7aR)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine-4-carboxylate
CAS No.1932146-99-0
PubChem CID75531151

Safety Data

Pictogram
Health hazard
Signal Word
N/A

Synthetic Route by SureRoute

1. ACDKJE961 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDKJE961 route product structure diagram
    ACDKJE9611932146-99-0 In Stock
Inquiry

2. ACDKJE961 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDKJE961 route product structure diagram
    ACDKJE9611932146-99-0 In Stock
Inquiry

Comments (0)